Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Shen, Cong Xiang ^a   Wen, Zhong ^a   Qian, Yu Hong ^a   Mu, Shao Feng ^a   Guan, Xiao Fang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; HYBRID PROTEIN; PLASMID VECTOR; TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE; THYMIDINE KINASE ENHANCED GREEN FLUORESCENT PROTEIN FUSION PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA; TELOMERASE; TERT PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVITY; FEMALE; FLUORESCENCE MICROSCOPY; GENE THERAPY; IMMEDIATE EARLY GENE; LIVER TOXICITY; MALE; MOUSE; NASOPHARYNX CARCINOMA; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; CYTOMEGALOVIRUS; ENZYMOLOGY; GENE VECTOR; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; NASOPHARYNX TUMOR; NUDE MOUSE; REGULATORY SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; CYTOMEGALOVIRUS; ENDOTHELIUM, VASCULAR; ENHANCER ELEMENTS, GENETIC; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; THYMIDINE KINASE;

EID: 77954412410     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-94     Document Type: Article

References (29)

1. 1 cell lines of NPC. Z Wen JY Xiao FQ Tang Y Tian S Zhao B Chen, Chinese Medical Journal 2000 113 525 8 11775871
2. Telomerase activation in nasopharyngeal carcinomas. RY Cheng PW Yuen JM Nicholls Z Zheng W Wei JS Sham XH Yang L Cao DP Huang SW Tsao, Br J Cancer 1998 77 456 60 9472643
3. An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter. YP Wang XJ Tang QH Zhou GW Che XH Chen DX Zhu, Sichuan Da Xue Xue Bao Yi Xue Ban 2008 39 701 5 19024294
4. Potent anti-tumor activity of telomerase-dependent and HSV-1TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo. J Zhang F Wei H Wang HM Li W Qui PK Ren XF Chen Q Huang, J Exp Clin Cancer Res 2010 29 52 10.1186/1756-9966-29-52 20487549
5. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. FQ Zheng Y Xu RJ Yang B Wu XH Tan YD Qin QW Zhang, Acta Pharmacol Sin 2009 30 617 27 10.1038/aps.2009.33 19363518
6. The effect of shRNA targeting hTERT on telomerase and the expression of PCNA and Caspase-3 in nasopharyngeal carcinoma cells. Y Shen Y Wang S Chen B Xiao J Su Z Tao, 2008 22 411 5
7. Down-regulation of telomerase and its RNA and apoptosis in HNE1 celllines of nasopharyngeal carcinama induced by hTR antisense oligonucleotide. Z Wen JY Xiao YQ Tian BL Chen, International. J. Modern Cancer Therapy 2000 3 77 81
8. TK gene targeted therapy mediated by the human telomerase promoter in nude mouse transplanted tumor of nasophyngeal carcinoma in vivo. SF Mu Z Wen MH Guo MQ Xie XF Guan CX Shen, Jie Fang Jun Yi Xue Za Zhi 2009 34 155 8
9. Tumor-specific TK gene therapy induced by hTERT promoter in human nasopharyngeal carcinoma (NPC) cells in vitro. F Xu Z Wen YZ Qiu JY Xiao, Nan Fang Yi Ke Da Xue Xue Bao 2010 30 695 9 20423828
10. Isolation and identification of tumor-like stem cells from human nasopharyngeal carcinoma cell line. XF Guan Z Wen CX Shen SF Mu HZ Zhang MQ Xie MH Guo, Jie Fang Jun Yi Xue Za Zhi 2008 33 1461 4
11. Incorporation of prokaryotic enhancer for enhancement of gene expression driven by hTERT promoter. LN Wang Z Li ZG Xue,, et al. Chin J Cancer Prev Treat 2006 13 1125 30
12. In vitro research of enhanced suicide gene vector for cervix cancer therapy. LN Wang YK Zhang Y Zhou,, et al. China Medical Engineering 2006 14 567 75
13. Screening and preliminary analysis of the apoptosis- and proliferation-related genes in nasopharyngeal carcinoma. YB Zhou ZX Huang CP Ren B Zhu KT Yao, Nan Fang Yi Ke Da Xue Xue Bao 2009 29 645 7 19403385
14. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cell. XP Li G Li Y Peng HF Kung MC Lin, Biochem Biophys Res Commun 2004 315 212 8 10.1016/j.bbrc.2004.01.045 15013447
15. Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues. HB Zhang CP Ren XY Yang L Wang H Li M Zhao H Yang KT Yao, Histochem Cell Biol 2007 127 347 54 10.1007/s00418-006-0251-9 17139514
16. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. J Wang LP Guo LZ Chen YX Zeng SH Lu, Cancer Res 2007 67 3716 24 10.1158/0008-5472.CAN-06-4343 17440084
17. Prostate tumor-initiating cells: A new target for telomerase inhibition therapy? CO Marian JW Shay, Biochim Biophys Acta 2009 1792 289 96 19264126
18. Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter. T Takeda H Inaba M Yamazaki S Kyo T Miyamoto S Suzuki T Ehara T Kakizawa M Hara LJ DeGroot K Hashizume, JCEM 2003 88 3531 8 12915632
19. Adenovirus-mediated suicide gene therapy using the human telomerase catalyticsubunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line. JS Song HP Kim WS Yoon KW Lee MH Kim KT Kim HS Kim YT Kim, Biosci Biotechnol Biochem 2003 67 2344 50 10.1271/bbb.67.2344 14646192
20. hTERT promoter induces tumor-specific Bax gene expression and cell killing insyngenic mouse tumor model and prevents systemic toxicity. J Gu M Andreeff JA Roth B Fang, Gene Ther 2002 9 30 7 10.1038/sj.gt.3301619 11850720
21. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells. T Komata Y Kondo T Kanzawa H Ito S Hirohata S Koga H Sumiyoshi M Takakura M Inoue BP Barna IM Germano S Kyo S Kondo, Hum Gene Ther 2002 13 1015 25 10.1089/104303402753812421 12067435
22. An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells. S Bortolanza C Qian MG Kramer C Gomar J Prieto F Farinati R Hernandez-Alcoceba, J Mol Med 2005 83 736 47 10.1007/s00109-005-0681-1 15976917
23. Suppressing orthotopic pancreatic tumor growth with a fiber modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. D Jacob J Davis H Zhu L Zhang F Teraishi S Wu FC Marini III B Fang, Clin Cancer Res 2004 10 3535 41 10.1158/1078-0432.CCR-03-0512 15161713
24. Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro. H Kong ZH Huang Q Li LC Yang JL Yu Z Li, Nan Fang Yi Ke Da Xue Xue Bao 2008 28 907 10 18583225
25. Radiosensitization and anti-tumour effects of cytosine deaminase and thymidine kinase fusion suicide gene in human adenoid cystic carcinoma cells. SY Huang DS Zhang JQ Han N Zhang SZ Zhang WL Mu FC Wei, J Int Med Res 2009 37 479 90 19383243
26. Radio-activation of hTERT promoter in larynx squamous carcinoma cells: an 'indirected-activator' strategy in radio-gene-therapy. ZK Liao FX Zhou ZG Luo WJ Zhang J Xiong J Bao G Han MS Zhang CH Xie YF Zhou, Oncol Rep 2008 19 281 6 18097608
27. Sleeping Beauty-mediated suicide gene therapy of hepatocellular carcinoma. J Song C Kim ER Ochoa, Biosci Biotechnol Biochem 2009 73 165 8 10.1271/bbb.80581 19129627
28. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. SM Yang DC Fang JL Yang L Chen YH Luo GP Liang, Eur J Cancer Prev 2008 17 209 17 10.1097/CEJ.0b013e3282b71f0d 18414191
29. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells. Y Shen YW Zhang ZX Zhang ZH Miao J Ding, Cancer Biol Ther 2008 7 228 36 10.1158/1535-7163.MCT-08-0641 18059183